Skip to main navigation Skip to search Skip to main content

Effects of Exogenous Recombinant APC in Mouse Models of Ischemia Reperfusion Injury and of Atherosclerosis

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Activated protein C (APC) is a serine protease that has both anticoagulant and cytoprotective properties. The cytoprotective effects are protease activated receptor 1 (PAR-1) and endothelial protein C receptor (EPCR) dependent and likely underlie protective effects of APC in animal models of sepsis, myocardial infarction and ischemic stroke. S360A-(A) PC, a variant (A) PC that has no catalytic activity, binds EPCR and shifts pro-inflammatory signaling of the thrombin-PAR-1 complex to anti-inflammatory signaling. In this study we investigated effects of human (h) wt-PC, hS360A-PC, hwt-APC and hS360A-APC in acute (mouse model of acute myocardial ischemia/reperfusion (I/R) injury) and chronic inflammation (apoE(-/-) mouse model of atherosclerosis). All h(A) PC variants significantly reduced myocardial infarct area (p
Original languageEnglish
Article numbere101446
JournalPLOS ONE
Volume9
Issue number7
DOIs
Publication statusPublished - 17 Jul 2014

Fingerprint

Dive into the research topics of 'Effects of Exogenous Recombinant APC in Mouse Models of Ischemia Reperfusion Injury and of Atherosclerosis'. Together they form a unique fingerprint.

Cite this